Glaukos Corporation (GKOS) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GKOS Revenue Growth
Revenue Breakdown (FY 2019)
GKOS's revenue distribution by segment and geography for fiscal year 2019
By Product/Segment
By Geography
GKOS Revenue Analysis (2014–2025)
As of May 8, 2026, Glaukos Corporation (GKOS) generated trailing twelve-month (TTM) revenue of $551.3 million, reflecting explosive growth of +41.2% year-over-year. The most recent quarter (Q1 2026) recorded $150.6 million in revenue, up 5.2% sequentially.
Looking at the longer-term picture, GKOS's 5-year compound annual growth rate (CAGR) stands at +17.7%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $507.4 million in 2025, representing a new all-time high.
Revenue diversification analysis shows GKOS's business is primarily driven by Glaucoma (97%), and Corneal Health (3%). With over half of revenue concentrated in Glaucoma, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ATRC (+15.0% YoY), NVCR (+8.5% YoY), and TNDM (-6.8% YoY), GKOS has outperformed the peer group in terms of revenue growth. Compare GKOS vs ATRC →
GKOS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GKOSCurrent | $551M | +41.2% | +17.7% | -17.1% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 TNDM | $1.0B | -6.8% | +15.3% | -7.7% | |
 INSP | $912M | +8.9% | +51.2% | 5.6% | |
 EW | $6.1B | +11.2% | +6.7% | 27.0% |
GKOS Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $507.4M | +32.3% | $393.2M | 77.5% | $-86,733,000 | -17.1% |
| 2024 | $383.5M | +21.9% | $289.5M | 75.5% | $-122,366,000 | -31.9% |
| 2023 | $314.7M | +11.3% | $239.1M | 76.0% | $-128,700,000 | -40.9% |
| 2022 | $282.9M | -3.8% | $213.9M | 75.6% | $-82,313,000 | -29.1% |
| 2021 | $294.0M | +30.7% | $227.4M | 77.3% | $-32,872,000 | -11.2% |
| 2020 | $225.0M | -5.1% | $133.2M | 59.2% | $-123,553,000 | -54.9% |
| 2019 | $237.0M | +30.7% | $198.4M | 83.7% | $-50,292,000 | -21.2% |
| 2018 | $181.3M | +13.8% | $156.2M | 86.2% | $-13,002,000 | -7.2% |
| 2017 | $159.3M | +39.2% | $138.2M | 86.8% | $-2,281,000 | -1.4% |
| 2016 | $114.4M | +59.5% | $98.2M | 85.9% | $4.2M | 3.7% |
See GKOS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GKOS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GKOS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGKOS — Frequently Asked Questions
Quick answers to the most common questions about buying GKOS stock.
Is GKOS's revenue growth accelerating or slowing?
GKOS revenue is accelerating at +41.2% year-over-year, exceeding the 5-year CAGR of +17.7%. TTM revenue reached $551M. Growth momentum has increased versus prior periods.
What is GKOS's long-term revenue growth rate?
Glaukos Corporation's 5-year revenue CAGR of +17.7% reflects the sustained expansion pattern. Current YoY growth of +41.2% is above this long-term average.
How is GKOS's revenue distributed by segment?
GKOS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.